Organon & Co. reported results for the 2026 quarter, with revenue of $1.56B, net income of $108M and diluted EPS of $0.4, against $1.59B, $145M and $0.56 in the prior-year quarter, respectively.Financial Highlights¹ Reported as “Revenues”. ² Reported as “Net income”. ³ Reported as “Diluted earnings…
Shareholders approved the merger with Sun Pharma USA and the related executive compensation proposal. Quorum was established, and all formal procedures were followed. Final voting results will be filed with the SEC.Based on Organon & Co. [OGN] EGM 2026 Audio Transcript — Jul. 23 2026This is an AI-g…
Shareholders approved the merger agreement with Sun Pharma USA and a non-binding advisory vote on executive compensation related to the merger. The meeting confirmed a quorum, followed proper procedures, and final voting results will be filed with the SEC.Based on Organon & Co. [OGN] EGM 2026 Audio…
